Company / SG&A Expense
iRhythm Holdings, Inc. SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$492.6M
FY2025
5-year range
$274.8M / $492.6M
FY2021-FY2025
Trend
+17.7%
vs FY2024
Sector context
#66 of 152
Health Care
What the data says
At $493M, iRhythm Holdings, Inc.'s sg&a expense ranks #87 of 152 in the Health Care sector. SG&A Expense has increased for 9 consecutive years, from $52M in FY2016 to $493M in FY2025.
Based on SEC 10-K filings.
$493M in FY2025 with a 5-year CAGR of +20.1%.
Increased from $386M to $493M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +15.2%
- 5-Year CAGR
- +20.1%
- 10-Year CAGR
- -
Sector benchmark
#87 of 152 in Health CareTop 57% of 152This company $492.6M Sector average $182.7B
▼
-99.7% below sector average
Key checks
Key Insights
- iRhythm Holdings, Inc.'s sg&a expense has grown for 9 consecutive years.
- 5-year CAGR of +20.1%, indicating consistent growth.
- In FY2025, sg&a expense increased 17.7% year-over-year.
- Ranks #66 out of 152 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.35 (distress zone, below 1.8 threshold)
- Negative profit margin: -19.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $492.6M | +17.7% |
| FY2024 | $418.6M | +8.5% |
| FY2023 | $385.6M | +19.7% |
| FY2022 | $322.2M | +17.2% |
| FY2021 | $274.8M | +39.3% |
| FY2020 | $197.2M | +9.9% |
| FY2019 | $179.5M | +34.7% |
| FY2018 | $133.3M | +56.4% |
| FY2017 | $85.3M | +65.1% |
| FY2016 | $51.6M | +40.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026